Literature DB >> 6628532

Pharmacokinetics of pindolol in Kenyan Africans.

F D Juma.   

Abstract

The pharmacokinetics of pindolol was studied in 8 normal Africans following administration of a single oral 10 mg dose. The mean peak concentration was 30.2 +/- 5.0 ng X ml-1, the mean half-life (t1/2) of the elimination phase was 3.4 +/- 1.1 h, and the total body clearance was 628 +/- 13 ml X min-1. The apparent volume of distribution was 3.0 +/- 1.31 X kg-1. The values are the same as those reported in Europeans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628532     DOI: 10.1007/bf01037959

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

Review 1.  [Comparative pharmacokinetics of beta-blockers].

Authors:  J R Kiechel; J Meier
Journal:  Nouv Presse Med       Date:  1978-09-20

2.  Ineffectiveness of propranolol in hypertensive Jamaicans.

Authors:  G S Humphreys; D G Delvin
Journal:  Br Med J       Date:  1968-06-08

3.  Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.

Authors:  J Meier
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

4.  Experience with pindolol in African hypertensives.

Authors:  M S Abdullah
Journal:  East Afr Med J       Date:  1983-12

5.  Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.

Authors:  J Meier
Journal:  Cardiology       Date:  1979       Impact factor: 1.869

6.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15

7.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

  7 in total
  2 in total

1.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

Review 2.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.